KRAS and breast cancer: Furthermore, both breast cancer cell lines exhibited significant reductions in the levels of KRAS, RHOA, RAC1, and CDC42 proteins of 49, 40, 50, and 48%, respectively in MDA-MB-468 cells (Figure 3C).